Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy

被引：1
|
作者：
Buti, Maria [1 ,2 ]
Riveiro-Barciela, Mar [1 ,2 ]
Esteban, Rafael [1 ,2 ]
机构：
[1] Hosp Univ Vall dHebron, Internal Med Dept, Liver Unit, Gen Hosp, Passeig Vall dHebron 119-129,5th Floor, Barcelona 08035, Spain
[2] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
CLINICS IN LIVER DISEASE | 2021年 / 25卷 / 04期
关键词：
Hepatitis B; Tenofovir alafenomide (TAF); Therapy; TENOFOVIR DISOPROXIL FUMARATE; HEPATOCELLULAR-CARCINOMA; E-ANTIGEN; REAL-WORLD; VIRAL SUPPRESSION; NATURAL-HISTORY; ALAFENAMIDE TAF; ENTECAVIR ETV; CHB PATIENTS; RISK;
D O I：
10.1016/j.cld.2021.06.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：725 / 740
页数：16
相关论文
共 50 条
  • [1] Adherence to Anti-Viral Treatment for Chronic Hepatitis B
    Abu-Freha, Naim
    Abu Tailakh, Muhammad
    Fich, Alexander
    Abu Bader, Nasreen
    Shemer-Avni, Yonat
    Alsana, Farhan
    Gasper, Nava
    Abu-Kaf, Heba
    Etzion, Ohad
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 10
  • [2] IMMUNOLOGICAL AND ANTI-VIRAL THERAPY OF CHRONIC HEPATITIS-B VIRUS-INFECTION
    THOMAS, HC
    BASSENDINE, MF
    [J]. CLINICS IN GASTROENTEROLOGY, 1980, 9 (01): : 85 - 95
  • [3] Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure
    Man-Fung Yuen
    [J]. Hepatology International, 2015, 9 : 373 - 377
  • [4] Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure
    Yuen, Man-Fung
    [J]. HEPATOLOGY INTERNATIONAL, 2015, 9 (03) : 373 - 377
  • [5] Review article: chronic hepatitis B - anti-viral or immunomodulatory therapy?
    Rijckborst, V.
    Sonneveld, M. J.
    Janssen, H. L. A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (05) : 501 - 513
  • [6] Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B
    Wong, G. L. -H.
    Seto, W. -K.
    Wong, V. W. -S.
    Yuen, M. -F.
    Chan, H. L. -Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (06) : 730 - 737
  • [7] Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
    Liang, Y.
    Jiang, J.
    Su, M.
    Liu, Z.
    Guo, W.
    Huang, X.
    Xie, R.
    Ge, S.
    Hu, J.
    Jiang, Z.
    Zhu, M.
    Wong, V. W. -S.
    Chan, H. L. -Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (03) : 344 - 352
  • [8] HISTOLOGICAL IMPROVEMENT AFTER ANTI-VIRAL TREATMENT FOR CHRONIC HEPATITIS-B VIRUS-INFECTION
    BROOK, MG
    PETROVIC, L
    MCDONALD, JA
    SCHEUER, PJ
    THOMAS, HC
    [J]. JOURNAL OF HEPATOLOGY, 1989, 8 (02) : 218 - 225
  • [9] ANTI-VIRAL THERAPY IN HEPATITIS-B INFECTION
    MERIGAN, TC
    SMITH, JL
    POLLARD, RB
    NEAL, EA
    SAWHNEY, V
    GREGORY, PB
    ROBINSON, WS
    [J]. JOURNAL OF SUPRAMOLECULAR STRUCTURE, 1978, : 229 - 229
  • [10] ANTI-VIRAL THERAPY IN HEPATITIS-B INFECTION
    MERIGAN, TC
    ROBINSON, WS
    GREGORY, PB
    SMITH, JL
    POLLARD, RB
    GREENBERG, HB
    NEAL, EA
    SAWHNEY, V
    [J]. CLINICAL RESEARCH, 1978, 26 (03): : A559 - A559
12345